The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising, Update on FY results & Biz Structure

11 Jun 2019 07:23

RNS Number : 7901B
mporium Group PLC
11 June 2019
 

 

 11 June 2019

Mporium Group plc

("Mporium", the "Company or the "Group")

Fundraising and Update on Report and Accounts and Business Structure

 

Mporium Group plc (AIM:MPM), the technology firm delivering event-driven marketing, announces that it has conditionally raised £1.5 million by way of subscription, mainly from existing investors for a total of 150,000,000 new ordinary shares of 0.5p each in the capital of the Company ("Ordinary Shares") (the "Subscription Shares"), at an issue price of 1 pence per Subscription Share (the "Subscription").

 

Upon completion of the Subscription, the investors will also receive 150,000,000 warrants ("Warrants") exercisable between 10 December 2019 and 10 December 2021 with a subscription price of 1.5 pence per Warrant, the terms of the Warrants to be finalised and agreed with the relevant parties prior to Admission (as defined below).

 

The Company may accept additional conditional subscriptions prior to close of business on 13 June 2019.

The net proceeds of the Subscription will be used to restructure the business as set out below and to provide working capital.

 

With immediate effect, the Company will commence a major restructuring that will refocus the business on the performance-led MporiumX division due to underperformance in the Agency division. The business will consequently narrow its focus to specific business sectors including both Sports and Consumer Regulation driven by its technology. Reflecting the new organisational structure, Tom Smith will be appointed Managing Director, Mporium Group plc. Tom will have wide-ranging responsibilities including the strategy and execution for the restructured business. Tom will continue to report to the CEO, Nelius De Groot. The Board now recognises that its gross margin aspirations will take longer to achieve and that as a consequence the Company will not achieve the desired EBITDA breakeven within 2019. As a result, the Company has concluded that the business should restructure and reduce its cost base materially.

 

The Company also wishes to provide a further update regarding the audited results for the financial year ended 31 December 2018. Due to the adoption of new accounting standards, the Company and its auditors are finalising the periods for which booked revenues will be recognised under these standards. These discussions are close to resolution and as stated in the update of 3 June 2019, the audit is being finalised and the Directors expect to announce audited results for such financial year by the end of June 2019.

 

Director change

The Executive Chairman, Barry Moat, has resigned with immediate effect. The Board will appoint a new Chairman as soon as practicable.

 

Related Party Transactions

Mr. Robert Keith currently holds 67,723,598 Ordinary Shares representing 8.01 per cent. of the existing share capital and is a connected party to Charles Street International Holdings ("Charles

Street"), which is a substantial shareholder of the Company for the purposes of the AIM Rules.

 

Mr. Robert Keith has conditionally subscribed for 50,000,000 Subscription Shares, and as a consequence of the status of Charles Street this subscription constitutes a Related Party Transaction under the AIM Rules. Following the Subscription, Robert Keith will hold 117,723,598 Ordinary Shares, representing 11.83 per cent. of the enlarged issued share capital (on the assumption no further Shares are issued in connection with the Subscription). The Directors consider, having consulted with finnCap Limited its Nominated Advisor, that the participation of Robert Keith is fair and reasonable insofar as the shareholders are concerned.

 

Conditions of Subscription

The Subscription is conditional upon (amongst other things): (i) Shareholders approving resolutions (amongst other things) authorising and empowering the directors of the Company to allot the Subscription Shares and issue the Subscription Warrants (and / or enter into agreements or other documents relating thereto) and to disapply pre-emption rights in respect thereof at the General Meeting referred to below, (ii) the terms of the Subscription Warrants being agreed as described above, (iii) admission ("Admission") of the Subscription Shares to trading on the AIM market of London Stock Exchange plc becoming effective by 8.00 a.m. on 4 July 2019 (or such later date 4being no later than 8.00 a.m. on 24 July 2019 as the Company may in its sole discretion determine) and (iv) receipt of funds in respect of the Subscription Shares from relevant investors.

 

The Subscription is not being underwritten. As the fundraise is conditional on receipt of funds from investors, the Company may complete the investment with certain investors and not with others and, accordingly, there is no minimum guaranteed amount to be raised by the fundraise.

 

Admission and Total Voting Rights

It is currently expected that a General Meeting of the Company will be convened for 10.00 a.m. on 2 July 2019 and will be held at the offices of the Company at First Floor, 106 New Bond Street, London W15 1DN. The Company will announce the posting of the notice convening the General Meeting and the accompanying Circular in due course.

 

Subject to all relevant conditions being satisfied (or, if applicable, waived), it is currently expected that the Subscription Shares will be admitted to trading on AIM at 8.00 a.m. on 4 July 2019 or such later time(s) and/or date(s) being no later than 8.00 a.m. on 24 July 2019 as the Company may in its absolute discretion determine.

 

Nelius De Groot, CEO of the Company, commented:

"The Group has decided that it is necessary to narrow the focus of our business and to take the necessary steps to restructure accordingly. We are confident that under Tom's leadership, the restructured business will provide the Company with a solid foundation for future growth. We would like to thank our shareholders for their continued support."

 

Enquiries Mporium:

020 3841 8411

Nelius De Groot, Chief Executive Officer

 

finnCap:

020 7220 0500

Henrik Persson / Kate Bannatyne (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

Yellow Jersey PR:

020 3004 9512

Tim Thompson / Joe Burgess

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGUGDLCUBBGCB
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.